Skip to content
Our Company
Culture and Values
Leadership
Corporate Impact
Environmental, Social, and Governance
Product Donations
Charitable Giving
CME and Research Grants
Careers
Open Roles
Life at Emergent
Locations
Our Focus
Biological Threats
Opioid Crisis
Manufacturing Partnerships
Our Science
Pipeline
Our Products
Product and Medical Inquiries
Latest
Press Releases
Blog
Podcast
Media Statements
Media Resources
Investors
FOLLOW US
Press Releases
February 20, 2015
Emergent BioSolutions to Participate in March 2015 Investor Conferences
...
Read More
February 13, 2015
Emergent BioSolutions Announces Primary Endpoints Met in Pivotal Study Supporting Licensure of Building 55
...
Read More
February 12, 2015
Emergent BioSolutions to Release Fourth Quarter and Full Year 2014 Financial Results and Conduct a Conference Call on March 5, 2015
...
Read More
January 11, 2015
Emergent BioSolutions Announces Preliminary 2014 Financial Results and Provides 2015 Financial Outlook
...
Read More
January 7, 2015
Emergent BioSolutions to Participate in January 2015 Investor Conferences
...
Read More
December 17, 2014
Emergent BioSolutions Expands Biodefense Franchise; Acquires Portfolio of Broad Spectrum Antibiotics
...
Read More
November 24, 2014
Emergent BioSolutions to Webcast Presentation at 25th Annual Oppenheimer Healthcare Conference
...
Read More
November 10, 2014
Emergent BioSolutions Seeks Expanded BioThrax Label; Submits FDA Application for Post-Exposure Prophylaxis
...
Read More
November 6, 2014
Emergent BioSolutions Reports Third Quarter and Nine Month 2014 Financial Results
...
Read More
October 20, 2014
Emergent BioSolutions to Webcast Presentation at Credit Suisse 2014 Healthcare Conference
...
Read More
October 9, 2014
Emergent BioSolutions to Release Third Quarter 2014 Financial Results and Conduct a Conference Call on November 6, 2014
...
Read More
September 23, 2014
Emergent BioSolutions Initiates Final Pivotal Study to Support Licensure of BioThrax at Large Scale
...
Read More
1
2
…
31
32
33
…
58
59
